Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma
- PMID: 37738154
- DOI: 10.1210/endocr/bqad139
Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma
Abstract
Oral squamous cell carcinoma (OSCC) is one of the most common malignancies and has a high mortality, posing a great threat to both human physical and mental health. With the advancement of scientific research, a variety of cancer therapies have been used for OSCC treatment. However, the prognosis of OSCC shows no significant improvement. Metformin has been recognized as the first-line drug for the treatment of diabetes, and recent studies have shown that metformin has a remarkable suppressive effect on tumor progression. Metformin can not only affect the energy metabolism of tumor cells but also play an antitumor role by modulating the tumor microenvironment and cancer stem cells. In this review, the molecular mechanism of metformin and its anticancer mechanism in OSCC are summarized. In addition, this article summarizes the side effects of metformin and the future prospects of its application in the treatment of OSCC.
Keywords: OSCC; cancer stem cells; metformin; tumor microenvironment.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.BMC Cancer. 2012 Nov 14;12:517. doi: 10.1186/1471-2407-12-517. BMC Cancer. 2012. PMID: 23151022 Free PMC article.
-
Metformin inhibits proliferation of oral squamous cell carcinoma cells by suppressing proteolysis of nerve growth factor receptor.Arch Oral Biol. 2021 Jan;121:104971. doi: 10.1016/j.archoralbio.2020.104971. Epub 2020 Nov 7. Arch Oral Biol. 2021. PMID: 33220581
-
In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.Eur J Pharmacol. 2021 Jan 15;891:173757. doi: 10.1016/j.ejphar.2020.173757. Epub 2020 Nov 26. Eur J Pharmacol. 2021. PMID: 33249080
-
Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.Diagn Pathol. 2017 Apr 5;12(1):32. doi: 10.1186/s13000-017-0623-6. Diagn Pathol. 2017. PMID: 28381274 Free PMC article. Review.
-
[Role of innate lymphoid cells in oral squamous cell carcinoma microenvironment].Zhonghua Kou Qiang Yi Xue Za Zhi. 2024 Apr 9;59(4):394-399. doi: 10.3760/cma.j.cn112144-20240129-00041. Zhonghua Kou Qiang Yi Xue Za Zhi. 2024. PMID: 38548598 Review. Chinese.
Cited by
-
A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer.Cancers (Basel). 2024 Aug 29;16(17):3017. doi: 10.3390/cancers16173017. Cancers (Basel). 2024. PMID: 39272875 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical